📰 Ichor Life Sciences News
Ichor Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ichor Life Sciences. Real-time updates on events, politics, business and more.
May 20, 2024
The growing company, which focuses on therapies for age-related diseases, received state help for a move from suburbs.
May 20, 2024
Subscribe to get the Good Morning, CNY newsletter delivered to your email inbox weekday mornings.
November 8, 2023
Aubrey de Grey reports on the large mouse study of combination antiaging treatments.
August 31, 2023
The report from the trenches of the first day of the 10th Aging Research for Drug Discovery, Copenhagen, August 29, 2023
August 22, 2023
The sixth-annual Longevity+DeSci summit recently convened for its third in-person event in New York City.
September 6, 2022
POTSDAM, NY / ACCESSWIRE / September 6, 2022 / Lento Bio, Inc., a preclinical pharmaceutical company developing small-molecule therapeutics to restore ocular lens flexibility and near-vision in presbyopia
August 15, 2022
LAFAYETTE, NY / ACCESSWIRE / August 15, 2022 / Ichor Life Sciences, a preclinical contract research organization, today announced a $1.5 million investment in
June 21, 2022
POTSDAM — A pre-clinical research company based in Potsdam is developing an eye drop to prevent age-related loss of vision.
June 15, 2022
/PRNewswire/ -- NOVOS, a company that develops science-based products to slow down aging, announced results of two studies demonstrating that the combination...
March 17, 2022
POTSDAM — Clarkson University Lewis School of Health Sciences Research Professor Aaron J. Wolfe has co-published a paper in the journal Nature Communications. Wolfe is also the chief science officer